[2017年欧洲心脏病学会（ESC）与欧洲心胸外科学会（EACTS）合作制定的冠状动脉疾病双联抗血小板治疗重点更新版。] - Suppr

[2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.].

作者信息

Valgimigli Marco, Bueno Héctor, Byrne Robert A, Collet Jean-Philippe, Costa Francesco, Jeppsson Anders, Jüni Peter, Kastrati Adnan, Kolh Philippe, Mauri Laura, Montalescot Gilles, Neumann Franz-Josef, Peticevic Mate, Roffi Marco, Steg Philippe Gabriel, Windecker Stephan, Zamorano Jose Luis

机构信息

Cardiology, Inselspital, Bern.

出版信息

Kardiol Pol. 2017;75(12):1217-1299. doi: 10.5603/KP.2017.0224.

DOI:10.5603/KP.2017.0224

PMID:29251754

Abstract

摘要

相似文献

[2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.].

Kardiol Pol. 2017;75(12):1217-1299. doi: 10.5603/KP.2017.0224.

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.

Eur J Cardiothorac Surg. 2018 Jan 1;53(1):34-78. doi: 10.1093/ejcts/ezx334.

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).

Eur Heart J. 2018 Jan 14;39(3):213-260. doi: 10.1093/eurheartj/ehx419.

[2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: What is new?].

Turk Kardiyol Dern Ars. 2018 Jan;46(1):1-6. doi: 10.5543/tkda.2017.77775.

2017 European Society of Cardiology (ESC) focused update on dual antiplatelet therapy in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).

Eur J Cardiothorac Surg. 2018 Jan 1;53(1):3-4. doi: 10.1093/ejcts/ezx333.

Case-based implementation of the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease.

Eur Heart J. 2018 Jan 14;39(3):e1-e33. doi: 10.1093/eurheartj/ehx503.

Review of the 2017 European Society of Cardiology's Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting with ST-Segment Elevation and Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease Developed in Collaboration with the European Association for Cardio-Thoracic Surgery.

J Cardiothorac Vasc Anesth. 2019 Aug;33(8):2334-2343. doi: 10.1053/j.jvca.2018.09.032. Epub 2018 Sep 27.

Changes and innovations of the 2017 ESC guidelines on dual antiplatelet therapy in coronary artery disease-a review.

Wien Klin Wochenschr. 2018 Dec;130(23-24):694-697. doi: 10.1007/s00508-018-1357-5. Epub 2018 Jul 20.

Influence of Different β-Blockers on Platelet Aggregation in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy.

J Cardiovasc Pharmacol Ther. 2016 Jan;21(1):44-52. doi: 10.1177/1074248415581175. Epub 2015 Apr 13.

The art of delivering evidence-based dual antiplatelet therapy.

J Fam Pract. 2018 Dec;67(12):758-766.

引用本文的文献

Assessing the efficacy and safety of low dose clopidogrel in Chinese ACS patients undergoing PCI: A retrospective study.

Medicine (Baltimore). 2025 May 30;104(22):e42551. doi: 10.1097/MD.0000000000042551.

Association of Anaesthetists guidelines: the use of blood components and their alternatives.

Anaesthesia. 2025 Apr;80(4):425-447. doi: 10.1111/anae.16542. Epub 2025 Jan 9.

Breaking boundaries: Ticagrelor monotherapy in high-risk patients.

Int J Cardiol Heart Vasc. 2024 Oct 20;55:101526. doi: 10.1016/j.ijcha.2024.101526. eCollection 2024 Dec.

De-Escalation Dual Antiplatelet Therapy Prevail over Potent P2Y12 Inhibitor Monotherapy in Patients with Acute Coronary Syndrome Undergone Percutaneous Coronary Intervention: A Network Meta-Analysis.

Rev Cardiovasc Med. 2022 Oct 25;23(11):360. doi: 10.31083/j.rcm2311360. eCollection 2022 Nov.

Incidence and outcomes of high bleeding risk patients with type 1 and type 2 myocardial infarction in a community-based cohort: Application of the Academic Research Consortium High Bleeding Risk Criteria.

Int J Cardiol. 2024 Feb 1;396:131565. doi: 10.1016/j.ijcard.2023.131565. Epub 2023 Oct 30.

Drug-coated balloons for treating lesions in large coronary vessels: A case report.

World J Clin Cases. 2023 Jul 16;11(20):4920-4925. doi: 10.12998/wjcc.v11.i20.4920.

Impact of Low-Dose Prasugrel on Platelet Reactivity in Chronic Phase of Post-Percutaneous Coronary Intervention (CHAPERON): a Prospective Cohort Study.

Cardiovasc Drugs Ther. 2024 Oct;38(5):947-957. doi: 10.1007/s10557-023-07454-z. Epub 2023 Apr 25.

Antithrombotic treatment strategy for patients with coronary artery ectasia and acute myocardial infarction: A case report.

World J Clin Cases. 2022 Apr 26;10(12):3936-3943. doi: 10.12998/wjcc.v10.i12.3936.

Effects of Aspirin Therapy on Bypass Efficacy and Survival of Patients Receiving Direct Cerebral Revascularization.

Front Pharmacol. 2022 May 3;13:841174. doi: 10.3389/fphar.2022.841174. eCollection 2022.

Bilateral multifocal muscular hemorrhage in the triceps surae during antiplatelet therapy: a case report.

J Int Med Res. 2021 Dec;49(12):3000605211064391. doi: 10.1177/03000605211064391.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.].

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献